Company: AEMD
Filing Date: 2025-09-05
Form Type: 424B4
Source: 0001683168-25-006701
Chunk: 67

Company: AETHLON MEDICAL INC
Filing Date: 2025-09-05
Form: 424B4
Chunk 67
---
 lock-up period of 60 days following
the date of closing of the offering pursuant to this prospectus. This means that, during the applicable lock-up period, we and such
persons may not offer for sale, contract to sell, sell, distribute, grant any option, right or warrant to purchase, pledge, hypothecate
or otherwise dispose of, directly or indirectly, any of our shares of common stock or any securities convertible into, or exercisable
or exchangeable for, shares of common stock, subject to customary exceptions. The placement agent may waive the terms of these lock-up
agreements in its sole discretion and without notice. In addition, we have agreed to not issue any securities that are subject to a price
reset based on the trading prices of our common stock or upon a specified or contingent event in the future or enter into any agreement
to issue securities at a future determined price for a period of one year following the closing date of this offering. The placement agent
may waive this prohibition in its sole discretion and without notice.

Regulation M

The placement agent may be deemed
to be an underwriter within the meaning of Section 2(a)(11) of the Securities Act, and any commissions received by it and any profit
realized on the resale of the securities sold by it while acting as principal might be deemed to be underwriting discounts or commissions
under the Securities Act. As an underwriter, the placement agent would be required to comply with the requirements of the Securities
Act and the Securities Exchange Act of 1934, as amended, or the Exchange Act, including, without limitation, Rule 10b-5 and Regulation
M under the Exchange Act. These rules and regulations may limit the timing of purchases and sales of our securities by the placement
agent acting as principal. Under these rules and regulations, the placement agent (i) may not engage in any stabilization activity
in connection with our securities and (ii) may not bid for or purchase any of our securities or attempt to induce any person to
purchase any of our securities, other than as permitted under the Exchange Act, until it has completed its participation in the distribution.

| 42 |

Indemnification

We have agreed to indemnify the
placement agent against certain liabilities, including certain liabilities arising under the Securities Act, or to contribute to payments
that the placement agent may be required to make for these liabilities.

Determination of Offering Price and Warrant Exercise Price

The actual offering price of
the securities we